Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Sleep Disturbances in Parkinson's Disease
NCT01442610Phase 4Completed
- Sponsor
- Technische Universität Dresden
- Start
- Oct 2011
- Primary completion
- Mar 2015
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by Technische Universität Dresden. Started Oct 2011; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01442610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442610.